Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Restructuring Costs: 2009-2024

Historic Restructuring Costs for Amicus Therapeutics (FOLD) over the last 7 years, with Dec 2024 value amounting to $9.2 million.

  • Amicus Therapeutics' Restructuring Costs was N/A to $3.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $9.2 million, marking a year-over-year change of. This contributed to the annual value of $9.2 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Amicus Therapeutics reported Restructuring Costs of $9.2 million as of FY2024, which was up 13,215.94% from $69,000 recorded in FY2016.
  • Amicus Therapeutics' Restructuring Costs' 5-year high stood at $9.2 million during FY2024, with a 5-year trough of $9.2 million in FY2024.
  • Over the past 1 years, Amicus Therapeutics' median Restructuring Costs value was $9.2 million (recorded in 2024), while the average stood at $9.2 million.